- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/15 - Natural-killer [NK] cellsNatural-killer T [NKT] cells
Patent holdings for IPC class A61K 40/15
Total number of patents in this class: 369
10-year publication summary
|
0
|
0
|
3
|
8
|
12
|
21
|
10
|
7
|
182
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immunitybio, Inc. | 481 |
25 |
| Board of Regents, The University of Texas System | 5966 |
13 |
| Nkarta, Inc. | 69 |
11 |
| Takeda Pharmaceutical Company Limited | 2707 |
9 |
| FATE Therapeutics, Inc. | 216 |
8 |
| GC Cell Corporation | 54 |
8 |
| Research Institute at Nationwide Children's Hospital | 586 |
6 |
| University of Central Florida Research Foundation, Inc. | 1217 |
6 |
| Indapta Therapeutics Inc. | 22 |
6 |
| Memorial Sloan-Kettering Cancer Center | 1980 |
5 |
| National University of Singapore | 2519 |
5 |
| Sloan-Kettering Institute for Cancer Research | 556 |
5 |
| Memorial Hospital for Cancer and Allied Diseases | 335 |
5 |
| Century Therapeutics, Inc. | 41 |
5 |
| The Regents of the University of California | 20324 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6553 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2921 |
4 |
| The Johns Hopkins University | 5762 |
3 |
| City of Hope | 1008 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2620 |
3 |
| Other owners | 231 |